The expanded partnership between Veeva Systems and Lotus Clinical Research is expected to have a positive short-term impact on Veeva's stock price. The adoption of Veeva Vault Clinical Suite by Lotus demonstrates the value of Veeva's product offerings and may lead to increased demand from other companies in the clinical research sector. This could result in higher revenues and a positive outlook for Veeva Systems.